{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:55:50Z","timestamp":1775670950248,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12325-013-0054-z","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T09:39:33Z","timestamp":1380188373000},"page":"819-833","source":"Crossref","is-referenced-by-count":78,"title":["OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology"],"prefix":"10.1007","volume":"30","author":[{"given":"David","family":"Ginsberg","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Sender","family":"Herschorn","sequence":"additional","affiliation":[]},{"given":"Angelo","family":"Gousse","sequence":"additional","affiliation":[]},{"given":"V\u00e9ronique","family":"Keppenne","sequence":"additional","affiliation":[]},{"given":"Philip","family":"Aliotta","sequence":"additional","affiliation":[]},{"given":"Karl-Dietrich","family":"Sievert","sequence":"additional","affiliation":[]},{"given":"Mitchell F.","family":"Brin","sequence":"additional","affiliation":[]},{"given":"Brenda","family":"Jenkins","sequence":"additional","affiliation":[]},{"given":"Catherine","family":"Thompson","sequence":"additional","affiliation":[]},{"given":"Wayne","family":"Lam","sequence":"additional","affiliation":[]},{"given":"John","family":"Heesakkers","sequence":"additional","affiliation":[]},{"given":"Cornelia","family":"Haag-Molkenteller","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,9,27]]},"reference":[{"key":"54_CR1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1464-410X.1997.00191.x","volume":"79","author":"SJ Foley","year":"1997","unstructured":"Foley SJ, McFarlane JP, Shah PJ. Vesico-ureteric reflux in adult patients with spinal injury. Br J Urol. 1997;79:888\u201391.","journal-title":"Br J Urol"},{"key":"54_CR2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00002060-200112000-00008","volume":"80","author":"BL Hicken","year":"2001","unstructured":"Hicken BL, Putzke JD, Richards JS. Bladder management and quality of life after spinal cord injury. Am J Phys Med Rehabil. 2001;80:916\u201322.","journal-title":"Am J Phys Med Rehabil"},{"key":"54_CR3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005;174:196\u2013200.","journal-title":"J Urol"},{"key":"54_CR4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","volume":"52","author":"B Schurch","year":"2007","unstructured":"Schurch B, Denys P, Kozma CM, et al. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol. 2007;52:850\u20138.","journal-title":"Eur Urol"},{"key":"54_CR5","doi-asserted-by":"crossref","unstructured":"Apostolidis A, Thompson C, Yan X, Mourad S. An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity. World J Urol. 2012 (Epub ahead of print).","DOI":"10.1007\/s00345-012-0984-0"},{"key":"54_CR6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60:742\u201350.","journal-title":"Eur Urol"},{"key":"54_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","volume":"187","author":"D Ginsberg","year":"2012","unstructured":"Ginsberg D, Gousse A, Keppenne V, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187:2131\u20139.","journal-title":"J Urol"},{"key":"54_CR8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.apmr.2007.02.009","volume":"88","author":"B Schurch","year":"2007","unstructured":"Schurch B, Denys P, Kozma CM, et al. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil. 2007;88:646\u201352.","journal-title":"Arch Phys Med Rehabil"},{"key":"54_CR9","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","volume":"184","author":"R Dmochowski","year":"2010","unstructured":"Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010;184:2416\u201322.","journal-title":"J Urol"},{"key":"54_CR10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","volume":"185","author":"S Khan","year":"2011","unstructured":"Khan S, Game X, Kalsi V, et al. Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis. J Urol. 2011;185:1344\u20139.","journal-title":"J Urol"},{"key":"54_CR11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/AOG.0b013e3181a1f5ea","volume":"113","author":"TM Kessler","year":"2009","unstructured":"Kessler TM, Khan S, Panicker J, et al. Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life. Obstet Gynecol. 2009;113:1046\u201351.","journal-title":"Obstet Gynecol"},{"key":"54_CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.2006.06258.x","volume":"98","author":"SM Finney","year":"2006","unstructured":"Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006;98:503\u20137.","journal-title":"BJU Int"},{"key":"54_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sc.1996.51","volume":"34","author":"SM Szollar","year":"1996","unstructured":"Szollar SM, Lee SM. Intravesical oxybutynin for spinal cord injury patients. Spinal Cord. 1996;34:284\u20137.","journal-title":"Spinal Cord"},{"key":"54_CR14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol. 2006;49:644\u201350.","journal-title":"Eur Urol"},{"key":"54_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol. 2008;53:275\u201387.","journal-title":"Eur Urol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0054-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T22:37:04Z","timestamp":1498084624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0054-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0054-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}